Cargando…
The promising role of antibody drug conjugate in cancer therapy: Combining targeting ability with cytotoxicity effectively
INTRODUCTION: Traditional cancer therapy has many disadvantages such as low selectivity and high toxicity of chemotherapy, as well as insufficient efficacy of targeted therapy. To enhance the cytotoxic effect and targeting ability, while reducing the toxicity of antitumor drugs, an antibody drug con...
Autores principales: | Li, Wen‐Qian, Guo, Han‐Fei, Li, Ling‐Yu, Zhang, Yong‐Fei, Cui, Jiu‐Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290258/ https://www.ncbi.nlm.nih.gov/pubmed/34165267 http://dx.doi.org/10.1002/cam4.4052 |
Ejemplares similares
-
Sulfiredoxin‐1 is a promising novel prognostic biomarker for hepatocellular carcinoma
por: Rao, Qian‐Wen, et al.
Publicado: (2020) -
Cost‐effectiveness analysis of first‐line treatments for advanced epidermal growth factor receptor‐mutant non‐small cell lung cancer patients
por: Li, Wen‐Qian, et al.
Publicado: (2021) -
Improved targeting of an anti‐TAG‐72 antibody drug conjugate for the treatment of ovarian cancer
por: Minnix, Megan, et al.
Publicado: (2020) -
Targeting cancer with antibody-drug conjugates: Promises and challenges
por: Dean, Alexis Q., et al.
Publicado: (2021) -
Internal enhancement of DNA damage by a novel bispecific antibody‐drug conjugate‐like therapeutics via blockage of mTOR and PD‐L1 signal pathways in pancreatic cancer
por: Cao, Rui, et al.
Publicado: (2019)